Use of a gestagen in combination with an estrogen and one or more pharmaceutically tolerable excipients/carriers for lactose-free oral contraceptive

Details for Australian Patent Application No. 2008324549 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Claussen, Claus; Burglen, Beate; Ladwig, Ralf; Pfeifer, Manuela; Fricke, Sabine

Agent Davies Collison Cave

Pub. Number AU-A-2008324549

PCT Pub. Number WO2009/059690

Priority 07021465.5 05.11.07 EP

Filing date 22 October 2008

Wipo publication date 14 May 2009

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 15/16 (2006.01) Drugs for genital or sexual disorders

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/059690 Priority application(s): WO2009/059690

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008324560-Autonomic rotor system for an aircraft

2008324548-Method for harvesting sugarcane and harvesting machine